These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 1747720)

  • 21. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
    Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
    Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Serum immunosuppressive acidic protein and natural killer cell activity in patients with metastatic renal cell carcinoma before and after nephrectomy.
    Fujikawa K; Matsui Y; Miura K; Kobayashi T; Oka H; Fukuzawa S; Takeuchi H
    J Urol; 2000 Sep; 164(3 Pt 1):673-5. PubMed ID: 10953123
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Study of immunosuppressive acidic protein (IAP) in patients with renal cell cancer].
    Shibayama T; Nakazono M; Koyama Y; Deguchi N; Baba S; Jitsukawa S; Murai M; Tazaki H
    Gan No Rinsho; 1984 May; 30(5):481-6. PubMed ID: 6727048
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Clinicopathologic features of renal cell carcinoma incidentally detected through radiological studies].
    Bulnes Vázquez V; Alvarez-Múgica M; Fernández Gómez JM; Nava Tomás E; Jalón Monzón A; Meilán Martínez A
    Actas Urol Esp; 2008; 32(10):976-84. PubMed ID: 19143288
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Management of asymptomatic small tumor of the kidney of incidental discovery].
    Smaoui S; Fanton Y; Peraldi R; Pernin F
    Prog Urol; 1998 Sep; 8(4):511-6. PubMed ID: 9834513
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Accidental discovery of renal cancer by ultrasonography].
    Michel F; Gattegno B; Cohen L; Fiatte P; Thibault P
    Presse Med; 1989 Apr; 18(13):671-4. PubMed ID: 2524038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical evaluation of serum basic fetoprotein--comparative study of serum immunosuppressive acid protein].
    Gohji K; Arakawa S; Matsumoto O; Kamidono S; Oshima H; Nagata H; Iwamoto T; Hirooka K; Shimatani N; Inoue T
    Nihon Hinyokika Gakkai Zasshi; 1989 May; 80(5):711-8. PubMed ID: 2474083
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Renal cell carcinoma: evaluation of the 1997 TNM system and recommendations for follow-up after surgery.
    Gofrit ON; Shapiro A; Kovalski N; Landau EH; Shenfeld OZ; Pode D
    Eur Urol; 2001 Jun; 39(6):669-74; discussion 675. PubMed ID: 11464056
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Incidentally discovered solid renal masses: what are they?
    Ozen H; Colowick A; Freiha FS
    Br J Urol; 1993 Sep; 72(3):274-6. PubMed ID: 8220985
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Incidental renal carcinoma].
    Hornák M; Skablová D; Bárdos A; Ondrus D
    Bratisl Lek Listy; 1998 Jun; 99(6):322-6. PubMed ID: 9721468
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [How accurate is the correlation between clinical and pathological TNM stages in renal tumours?].
    Frommhold J; Jocham D; Doehn C
    Aktuelle Urol; 2011 Jul; 42(4):247-51. PubMed ID: 21717400
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Incidentally detected renal cell carcinoma: pathological features, survival trends and implications for treatment.
    Sweeney JP; Thornhill JA; Graiger R; McDermott TE; Butler MR
    Br J Urol; 1996 Sep; 78(3):351-3. PubMed ID: 8881940
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Serum ferritin as a clinical marker for renal cell carcinoma: influence of tumor size and volume.
    Kirkali Z; Güzelsoy M; Mungan MU; Kirkali G; Yörükoglu K
    Urol Int; 1999; 62(1):21-5. PubMed ID: 10436426
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [A kidney tumor as an incidental ultrasound finding].
    Reuss J
    Ultraschall Med; 1994 Aug; 15(4):163-7. PubMed ID: 7973584
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pathological stage does not alter the prognosis for renal lesions determined to be stage T1 by computerized tomography.
    Roberts WW; Bhayani SB; Allaf ME; Chan TY; Kavoussi LR; Jarrett TW
    J Urol; 2005 Mar; 173(3):713-5. PubMed ID: 15711249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Renal cell carcinoma: incidental detection.
    Lanctin HP; Futter NG
    Can J Surg; 1990 Dec; 33(6):488-90. PubMed ID: 2253127
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Immunosuppressive acidic protein (IAP) and immunosuppressive substance (ISS) in patients with renal cell carcinoma].
    Yamazaki K; Kumamoto Y; Tsukamoto T; Ohmura K; Miyao N; Yoshioka M; Iwasawa A
    Hinyokika Kiyo; 1991 May; 37(5):467-74. PubMed ID: 1858580
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serum level of immunosuppressive acidic protein in patients with urological malignancies.
    Pu YS; Tsai TC; Chiu TY; Hsieh TS; Chen J; Chen SC; Lin MC; Hsu TC
    J Formos Med Assoc; 1991 May; 90(5):498-503. PubMed ID: 1680990
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Incidentally detected renal cell carcinoma: role of ultrasonography.
    Porena M; Vespasiani G; Rosi P; Costantini E; Virgili G; Mearini E; Micali F
    J Clin Ultrasound; 1992; 20(6):395-400. PubMed ID: 1328311
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Evaluation of five glycoprotein tumour markers (CEA, CA-50, CA-19-9, CA-125, CA-15-3) for the prognosis of renal-cell carcinoma.
    Grankvist K; Ljungberg B; Rasmuson T
    Int J Cancer; 1997 Apr; 74(2):233-6. PubMed ID: 9133462
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.